Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03937687 · ClinicalTrials.gov registry record · Early Phase 1
The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement
A Early Phase 1 study, sponsored by University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 49
- Enrollment target
NCT03937687 is a Early Phase 1 study that has completed, run by University of South Carolina. The registered enrollment target is 49 participants.
The verdict
NCT03937687, a Early Phase 1 study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic variables in response to this combination.
Interventions
- DRUG Placebo
- DRUG Caffeine
- DRUG Caffeine+TeaCrine+Dynamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2019-05-04 |
| Est. Completion | 2020-11-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03937687
The ClinicalTrials.gov registry entry for NCT03937687 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03937687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03937687 about?
NCT03937687 is a clinical study titled "The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement". The purpose of this randomized, placebo-controlled, three-condition, double-blind, between-subjects clinical trial is to determine and compare the effects of the combination of TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and target acquisition and accuracy....
What is the current status of trial NCT03937687?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 49 participants. The study started on 2019-05-04. Estimated completion is 2020-11-15.
What interventions are being tested in trial NCT03937687?
The interventions under investigation include: Placebo (DRUG), Caffeine (DRUG), Caffeine+TeaCrine+Dynamine (DRUG).
Who is sponsoring clinical trial NCT03937687?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.